ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.155,24
-0,04%
S&P 500
5.477,90
0,16%
Dow Jones
39.127,80
0,04%
Euro vs US Dollar
1,06933
0,13%
Bitcoin
60.928,01
0,19%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. FibroBiologics Inc (FBLG)

  7. FibroBiologics Inc (FBLG) News

FBLG

FibroBiologics (FBLG)

FibroBiologics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FBLG
DatumZeitQuelleÜberschriftSymbolFirma
25/06/202415h31GlobeNewswire Inc.FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid TechnologyNASDAQ:FBLGFibroBiologics Inc
18/06/202422h12Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:FBLGFibroBiologics Inc
13/06/202415h31GlobeNewswire Inc.FibroBiologics Set to Join Russell 2000® IndexNASDAQ:FBLGFibroBiologics Inc
06/06/202416h58Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:FBLGFibroBiologics Inc
06/06/202415h31GlobeNewswire Inc.FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024NASDAQ:FBLGFibroBiologics Inc
04/06/202420h36Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:FBLGFibroBiologics Inc
15/05/202422h30GlobeNewswire Inc.FibroBiologics Announces 2024 Annual Meeting of StockholdersNASDAQ:FBLGFibroBiologics Inc
15/05/202422h02Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FBLGFibroBiologics Inc
14/05/202423h24GlobeNewswire Inc.FibroBiologics Files 2024 First Quarter ReportNASDAQ:FBLGFibroBiologics Inc
14/05/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBLGFibroBiologics Inc
07/05/202415h31GlobeNewswire Inc.FibroBiologics to Present at the BIO International Convention 2024NASDAQ:FBLGFibroBiologics Inc
25/04/202414h00GlobeNewswire Inc.FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based SpheroidsNASDAQ:FBLGFibroBiologics Inc
11/04/202415h31GlobeNewswire Inc.FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent OfficeNASDAQ:FBLGFibroBiologics Inc
04/04/202415h31GlobeNewswire Inc.FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USANASDAQ:FBLGFibroBiologics Inc
28/03/202414h31GlobeNewswire Inc.FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of LupusNASDAQ:FBLGFibroBiologics Inc
19/03/202414h31PR Newswire (US)FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes TreatmentNASDAQ:FBLGFibroBiologics Inc
19/03/202414h31PR Newswire (US)FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes TreatmentNASDAQ:FBLGFibroBiologics Inc
13/03/202414h31PR Newswire (US)FibroBiologics to Present at Advanced Wound Care Summit USANASDAQ:FBLGFibroBiologics Inc
06/03/202415h31PR Newswire (US)FibroBiologics Appoints Ruben A. Garcia as General CounselNASDAQ:FBLGFibroBiologics Inc
29/02/202423h44PR Newswire (US)FibroBiologics Files 2023 Form 10-K Annual ReportNASDAQ:FBLGFibroBiologics Inc
20/02/202415h31PR Newswire (US)FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) ForumNASDAQ:FBLGFibroBiologics Inc
13/02/202415h31PR Newswire (US)FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory DiseasesNASDAQ:FBLGFibroBiologics Inc
08/02/202415h31PR Newswire (US)FibroBiologics Announces Three United States Patents for Fibroblast TechnologyNASDAQ:FBLGFibroBiologics Inc
06/02/202415h31PR Newswire (US)FibroBiologics Announces Three Japanese Patents on Fibroblast TechnologyNASDAQ:FBLGFibroBiologics Inc
 Showing the most relevant articles for your search:NASDAQ:FBLG

Kürzlich von Ihnen besucht

NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AAPL
Apple
TG
ALV
Allianz
CCOM
SILVER
SILVER
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
TG
CBK
Commerzbank
TG
D7G
Nel ASA
COIN
SOLUSD
Solana
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
NASDAQ
GOOGL
Alphabet
CCOM
US30
US 30
TG
MBG
MercedesBenz
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten